Treatment of portal hypertension: Recommendations;Traitement de l'hypertension portale: Recommandations

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 3, 1999, Pages 353-354

  Calès, Paul ^a   Castaing, Denis ^b   Grangé, Jean Didier ^b   Lebrec, Didier ^b   Lemoine, Olivier ^b   Poynard, Thierry ^b   Silvain, Christine ^b   Sogni, Philippe ^b   Vinel, Jean Pierre ^b   Vons, Corinne ^b   Nouel, Olivier ^b   Bourgeois, Nadine ^b   Bernard, Brigitte ^b   Hadengue, Antoine ^b  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NADOLOL;

HUMAN; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; PRACTICE GUIDELINE; SCLEROTHERAPY; SHORT SURVEY; TREATMENT PLANNING; VEIN LIGATION;

HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; PRIMARY PREVENTION;

EID: 0033051188     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension : a meta-analytic review. Hepatology 1995;22:332-54.
2. De Franchis R. Developing consensus in portal hypertension. J Hepatol 1996;25:390-4.
3. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding : an AASLD single topic symposium. Hepatology 1998;28:868-80.